Scimed's Dispatch
This article was originally published in The Gray Sheet
Executive Summary
Full launch of firm's coronary infusion catheter is scheduled for late summer, Director of Investor Relations Karen Kelsey tells attendees of the Alex. Brown conference in Baltimore May 11. To date, more than 100 of the devices have been used clinically, Kelsey says. The product, which may be used to deliver agents to reduce restenosis, dissolve thrombus, and facilitate revascularization, has been sold on a limited basis since receiving clearance earlier this year ("The Gray Sheet" Jan. 17, p. 8)